{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:17:31Z","timestamp":1788419851635,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-022-06484-6","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T13:03:10Z","timestamp":1671627790000},"page":"2635-2649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Autonomic dysfunction and cardiovascular risk in psoriatic arthritis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8790-304X","authenticated-orcid":false,"given":"Halise Hande","family":"Gezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4805-0555","authenticated-orcid":false,"given":"Sevtap","family":"Acer Kasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-2788","authenticated-orcid":false,"given":"Mehmet Tuncay","family":"Duru\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"6484_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/nejmra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957\u2013970. https:\/\/doi.org\/10.1056\/nejmra1505557","journal-title":"N Engl J Med"},{"key":"6484_CR2","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Medina C, Chevret S, Molto A, Sieper J, Duru\u00f6z T, Kiltz U, Elzorkany B, Hajjaj-Hassouni N, Burgos-Vargas R, Maldonado-Cocco J, Ziade N, Gavali M, Navarro-Compan V, Luo SF, Biglia A, Tae-Jong K, Kishimoto M, Pimentel-Santos FM, Gu J, Muntean L, van Gaalen FA, Geher P, Magrey M, Ib\u00e1\u00f1ez-Vodnizza SE, Bautista-Molano W, Maksymowych W, Machado PM, Landew\u00e9 R, van der Heijde D, Dougados M (2021) Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD Open 7:e001728. https:\/\/doi.org\/10.1136\/rmdopen-2021-001728","DOI":"10.1136\/rmdopen-2021-001728"},{"key":"6484_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3899\/jrheum.121500","volume":"40","author":"JA Husted","year":"2013","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Gladman DD (2013) Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol 40:1349\u20131356. https:\/\/doi.org\/10.3899\/jrheum.121500","journal-title":"J Rheumatol"},{"key":"6484_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/acr.22926","volume":"69","author":"A Polachek","year":"2017","unstructured":"Polachek A, Touma Z, Anderson M, Eder L (2017) Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 69:67\u201374. https:\/\/doi.org\/10.1002\/acr.22926","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6484_CR5","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/acr.23567","volume":"70","author":"K Lauper","year":"2018","unstructured":"Lauper K, Courvoisier DS, Chevallier P, Finckh A, Gabay C (2018) Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Arthritis Care Res (Hoboken) 70:1756\u20131763. https:\/\/doi.org\/10.1002\/acr.23567","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6484_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semarthrit.2017.11.010","volume":"48","author":"SA Provan","year":"2018","unstructured":"Provan SA, Olstad DS, Solberg EE, Smedslund G, Dagfinrud H (2018) Evidence of reduced parasympathetic autonomic regulation in inflammatory joint disease: a meta-analyses study. Semin Arthritis Rheum 48:134\u2013140. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.11.010","journal-title":"Semin Arthritis Rheum"},{"key":"6484_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3899\/jrheum.141359","volume":"43","author":"N Haque","year":"2016","unstructured":"Haque N, Lories RJ, de Vlam K (2016) Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study. J Rheumatol 43:376\u2013382. https:\/\/doi.org\/10.3899\/jrheum.141359","journal-title":"J Rheumatol"},{"key":"6484_CR8","doi-asserted-by":"publisher","first-page":"786776","DOI":"10.3389\/fmed.2022.786776","volume":"9","author":"V Yagensky","year":"2022","unstructured":"Yagensky V, Schirmer M (2022) Cardiovascular risks and risk stratification in inflammatory joint diseases: a cross-sectional study. Front Med (Lausanne) 9:786776. https:\/\/doi.org\/10.3389\/fmed.2022.786776","journal-title":"Front Med (Lausanne)"},{"key":"6484_CR9","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/imj.14046","volume":"48","author":"P Sinnathurai","year":"2018","unstructured":"Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L (2018) Comorbidity in psoriatic arthritis and rheumatoid arthritis. Intern Med J 48:1360\u20131368. https:\/\/doi.org\/10.1111\/imj.14046","journal-title":"Intern Med J"},{"key":"6484_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"6484_CR11","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s10067-020-05088-2","volume":"39","author":"A Lorenzo","year":"2020","unstructured":"Lorenzo A, Pardo E, Charca L, Pino M, Queiro R (2020) Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis. Clin Rheumatol 39:2973\u20132979. https:\/\/doi.org\/10.1007\/s10067-020-05088-2","journal-title":"Clin Rheumatol"},{"key":"6484_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/rheumatology\/key286","volume":"58","author":"R Charlton","year":"2019","unstructured":"Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N (2019) Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study. Rheumatology (Oxford) 58:144\u2013148. https:\/\/doi.org\/10.1093\/rheumatology\/key286","journal-title":"Rheumatology (Oxford)"},{"key":"6484_CR13","doi-asserted-by":"publisher","first-page":"e0205506","DOI":"10.1371\/journal.pone.0205506","volume":"13","author":"L Navarini","year":"2018","unstructured":"Navarini L, Margiotta DPE, Caso F, Currado D, Tasso M, Angeletti S, Ciccozzi M, Scarpa R, Afeltra A, Costa L (2018) Performances of five risk algorithms in predicting cardiovascular events in patients with psoriatic arthritis: an Italian bicentric study. PLoS ONE 13:e0205506. https:\/\/doi.org\/10.1371\/journal.pone.0205506","journal-title":"PLoS ONE"},{"key":"6484_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindstr\u00f6m U, Askling J, Jacobsson LTH (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19:102. https:\/\/doi.org\/10.1186\/s13075-017-1315-z","journal-title":"Arthritis Res Ther"},{"key":"6484_CR15","doi-asserted-by":"publisher","first-page":"785719","DOI":"10.3389\/fmed.2022.785719","volume":"9","author":"Y Degbo\u00e9","year":"2022","unstructured":"Degbo\u00e9 Y, Koch R, Zabraniecki L, Jamard B, Couture G, Ruidavets JB, Ferrieres J, Ruyssen-Witrand A, Constantin A (2022) Increased cardiovascular risk in psoriatic arthritis: results from a case-control monocentric study. Front Med (Lausanne) 9:785719. https:\/\/doi.org\/10.3389\/fmed.2022.785719","journal-title":"Front Med (Lausanne)"},{"key":"6484_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2340\/00015555-2657","volume":"97","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Thyssen JP, Jensen P, Gislason GH, Skov L (2017) Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a nationwide cohort study. Acta Derm Venereol 97:819\u2013824. https:\/\/doi.org\/10.2340\/00015555-2657","journal-title":"Acta Derm Venereol"},{"key":"6484_CR17","doi-asserted-by":"publisher","unstructured":"Egeberg A, Skov L, Hansen PR, Gislason GH, Wu JJ, Thyssen JP, Mallbris L (2018) Duration of psoriatic arthritis as a risk factor for myocardial infarction. Rheumatol Adv Pract 2:rky011. https:\/\/doi.org\/10.1093\/rap\/rky011","DOI":"10.1093\/rap\/rky011"},{"key":"6484_CR18","doi-asserted-by":"publisher","unstructured":"Jatwani S, Jatwani K, Tiwari P, Wadhwa N, Chugh K (2021) Trends in hospitalisations and inpatient mortality from acute myocardial infarction among patients with psoriatic arthritis: an analysis of nationwide inpatient sample 2004\u20132014. Clin Exp Rheumatol 39:790\u2013794. https:\/\/doi.org\/10.55563\/clinexprheumatol\/kh5h6s","DOI":"10.55563\/clinexprheumatol\/kh5h6s"},{"key":"6484_CR19","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","volume":"56","author":"A Ogdie","year":"2017","unstructured":"Ogdie A, Maliha S, Shin D, Love TJ, Baker J, Jiang Y, Choi H, Gelfand JM (2017) Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford) 56:907\u2013911. https:\/\/doi.org\/10.1093\/rheumatology\/kew502","journal-title":"Rheumatology (Oxford)"},{"key":"6484_CR20","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jaad.2020.10.031","volume":"84","author":"K Colaco","year":"2021","unstructured":"Colaco K, Widdifield J, Luo J, Rosen CF, Alhusayen R, Paterson JM, Campbell W, Tu K, Bernatsky S, Gladman DD, Eder L (2021) Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada. J Am Acad Dermatol 84:1302\u20131309. https:\/\/doi.org\/10.1016\/j.jaad.2020.10.031","journal-title":"J Am Acad Dermatol"},{"key":"6484_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","volume":"76","author":"O Schieir","year":"2017","unstructured":"Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM (2017) Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis 76:1396\u20131404. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210275","journal-title":"Ann Rheum Dis"},{"key":"6484_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/joim.13311","volume":"290","author":"AB Tinggaard","year":"2021","unstructured":"Tinggaard AB, Hjuler KF, Andersen IT, Winther S, Iversen L, B\u00f8ttcher M (2021) Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi-centre cohort study. J Intern Med 290:693\u2013703. https:\/\/doi.org\/10.1111\/joim.13311","journal-title":"J Intern Med"},{"key":"6484_CR23","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1093\/eurheartj\/ehx145","volume":"39","author":"A Ogdie","year":"2018","unstructured":"Ogdie A, Kay McGill N, Shin DB, Takeshita J, Jon Love T, Noe MH, Chiesa Fuxench ZC, Choi HK, Mehta NN, Gelfand JM (2018) Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. Eur Heart J 39:3608\u20133614. https:\/\/doi.org\/10.1093\/eurheartj\/ehx145","journal-title":"Eur Heart J"},{"key":"6484_CR24","doi-asserted-by":"publisher","unstructured":"Galloway J, Barrett K, Irving P, Khavandi K, Nijher M, Nicholson R, de Lusignan S, Buch MH (2020) Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study. RMD Open 6(3):e001392. https:\/\/doi.org\/10.1136\/rmdopen-2020-001392","DOI":"10.1136\/rmdopen-2020-001392"},{"key":"6484_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13075-021-02703-8","volume":"24","author":"T Gazitt","year":"2022","unstructured":"Gazitt T, Pesachov J, Lavi I, Elias M, Haddad A, Feldhamer I, Cohen AD, Saliba W, Zisman D (2022) The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study. Arthritis Res Ther 24:16. https:\/\/doi.org\/10.1186\/s13075-021-02703-8","journal-title":"Arthritis Res Ther"},{"key":"6484_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3899\/jrheum.170379","volume":"45","author":"L Eder","year":"2018","unstructured":"Eder L, Harvey P, Chandran V, Rosen CF, Dutz J, Elder JT, Rahman P, Ritchlin CT, Rohekar S, Hayday R, Barac S, Feld J, Zisman D, Gladman DD (2018) Gaps in diagnosis and treatment of cardiovascular risk factors in patients with psoriatic disease: an international multicenter study. J Rheumatol 45:378\u2013384. https:\/\/doi.org\/10.3899\/jrheum.170379","journal-title":"J Rheumatol"},{"key":"6484_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/acr.23094","volume":"69","author":"K Jafri","year":"2017","unstructured":"Jafri K, Bartels CM, Shin D, Gelfand JM, Ogdie A (2017) Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 69:51\u201357. https:\/\/doi.org\/10.1002\/acr.23094","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6484_CR28","doi-asserted-by":"publisher","unstructured":"Landgren AJ, Dehlin M, Jacobsson L, Bergsten U, Klingberg E (2021) Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden. RMD Open 7(2):e001568. https:\/\/doi.org\/10.1136\/rmdopen-2021-001568","DOI":"10.1136\/rmdopen-2021-001568"},{"key":"6484_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/1756-185x.13421","volume":"22","author":"R Queiro","year":"2019","unstructured":"Queiro R, Lorenzo A, Tej\u00f3n P, Pardo E, Coto P, Ballina J (2019) Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis. Int J Rheum Dis 22:269\u2013274. https:\/\/doi.org\/10.1111\/1756-185x.13421","journal-title":"Int J Rheum Dis"},{"key":"6484_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00296-021-05064-2","volume":"42","author":"C Kavadichanda","year":"2022","unstructured":"Kavadichanda C, Shanoj KC, Ganapathy S, Shah SI, Ananthakrishnan R, Sahoo J, Negi VS (2022) Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis. Rheumatol Int 42:251\u2013260. https:\/\/doi.org\/10.1007\/s00296-021-05064-2","journal-title":"Rheumatol Int"},{"key":"6484_CR31","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/annrheumdis-2020-217595","volume":"79","author":"SHM Lam","year":"2020","unstructured":"Lam SHM, Cheng IT, Li EK, Wong P, Lee J, Yip RM, Yim CW, Ying SK, Li M, Li TK, Lee AP, Tam LS (2020) DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study. Ann Rheum Dis 79:1320\u20131326. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217595","journal-title":"Ann Rheum Dis"},{"key":"6484_CR32","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1093\/rheumatology\/keaa025","volume":"59","author":"IT Cheng","year":"2020","unstructured":"Cheng IT, Li EK, Wong PC, Law MY, Yim IC, Lai BT, Ying SK, Kwok KY, Li M, Li TK, Lee JJ, Szeto CC, Yan BP, Lee AP, Tam LS (2020) Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis-which target should we choose? Rheumatology (Oxford) 59:2881\u20132892. https:\/\/doi.org\/10.1093\/rheumatology\/keaa025","journal-title":"Rheumatology (Oxford)"},{"key":"6484_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5543\/tkda.2018.36169","volume":"46","author":"\u015e Apra\u015f Bilgen","year":"2018","unstructured":"Apra\u015f Bilgen \u015e, Kalyoncu U, Erden A, Canpolat U, K\u0131l\u0131\u00e7 L, Karada\u011f \u00d6, Aytemir K, Kiraz S, Akdo\u011fan A, Ertenli \u0130 (2018) Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factors. Turk Kardiyol Dern Ars 46:358\u2013365. https:\/\/doi.org\/10.5543\/tkda.2018.36169","journal-title":"Turk Kardiyol Dern Ars"},{"key":"6484_CR34","doi-asserted-by":"publisher","first-page":"204062232096506","DOI":"10.1177\/2040622320965067","volume":"11","author":"I Arias de la Rosa","year":"2020","unstructured":"Arias de la Rosa I, Font P, Escudero-Contreras A, L\u00f3pez-Montilla MD, P\u00e9rez-S\u00e1nchez C, \u00c1balos-Aguilera MC, Ladehesa-Pineda L, Ib\u00e1\u00f1ez-Costa A, Torres-Granados C, Jimenez-Gomez Y, Pati\u00f1o-Trives A, Luque-T\u00e9var M, Castro-Villegas MC, Calvo-Guti\u00e9rrez J, Ortega-Castro R, L\u00f3pez-Pedrera C, Collantes-Est\u00e9vez E, Barbarroja N (2020) Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis. Ther Adv Chronic Dis 11:2040622320965067. https:\/\/doi.org\/10.1177\/2040622320965067","journal-title":"Ther Adv Chronic Dis"},{"key":"6484_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/strokeaha.117.019312","volume":"49","author":"L Xiong","year":"2018","unstructured":"Xiong L, Tian G, Leung H, Soo YOY, Chen X, Ip VHL, Mok VCT, Chu WCW, Wong KS, Leung TWH (2018) Autonomic dysfunction predicts clinical outcomes after acute ischemic stroke: a prospective observational study. Stroke 49:215\u2013218. https:\/\/doi.org\/10.1161\/strokeaha.117.019312","journal-title":"Stroke"},{"key":"6484_CR36","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10067-012-2015-3","volume":"31","author":"I Gaydukova","year":"2012","unstructured":"Gaydukova I, Rebrov A, Nikitina N, Poddubnyy D (2012) Decreased heart rate variability in patients with psoriatic arthritis. Clin Rheumatol 31:1377\u20131381. https:\/\/doi.org\/10.1007\/s10067-012-2015-3","journal-title":"Clin Rheumatol"},{"issue":"3","key":"6484_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.semarthrit.2014.06.003","volume":"44","author":"AM Adlan","year":"2014","unstructured":"Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP (2014) Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 44(3):283\u2013304. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.06.003","journal-title":"Semin Arthritis Rheum"},{"key":"6484_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12975-019-00706-x","volume":"11","author":"S Rupprecht","year":"2020","unstructured":"Rupprecht S, Finn S, Hoyer D, Guenther A, Witte OW, Schultze T, Schwab M (2020) Association between systemic inflammation, carotid arteriosclerosis, and autonomic dysfunction. Transl Stroke Res 11:50\u201359. https:\/\/doi.org\/10.1007\/s12975-019-00706-x","journal-title":"Transl Stroke Res"},{"key":"6484_CR39","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-022-05110-7","volume":"42","author":"HH Gezer","year":"2022","unstructured":"Gezer HH, Erdem G\u00fcrsoy D, Acer Kasman S, Duru\u00f6z MT (2022) Assessment of autonomic dysfunction with the COMPASS-31 and its relationship with disease activity and cardiovascular risks in patients with psoriatic arthritis. Rheumatol Int 42:1539\u20131548. https:\/\/doi.org\/10.1007\/s00296-022-05110-7","journal-title":"Rheumatol Int"},{"key":"6484_CR40","doi-asserted-by":"publisher","first-page":"9933532","DOI":"10.1155\/2021\/9933532","volume":"2021","author":"C Brock","year":"2021","unstructured":"Brock C, Rasmussen SE, Drewes AM, M\u00f8ller HJ, Brock B, Deleuran B, Farmer AD, Pfeiffer-Jensen M (2021) Vagal nerve stimulation-modulation of the anti-inflammatory response and clinical outcome in psoriatic arthritis or ankylosing spondylitis. Mediators Inflamm 2021:9933532. https:\/\/doi.org\/10.1155\/2021\/9933532","journal-title":"Mediators Inflamm"},{"key":"6484_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13075-017-1358-1","volume":"19","author":"G Wibetoe","year":"2017","unstructured":"Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg \u00c5, Fevang BT, Gulseth HC, Haugeberg G, Semb AG (2017) Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Res Ther 19:153. https:\/\/doi.org\/10.1186\/s13075-017-1358-1","journal-title":"Arthritis Res Ther"},{"key":"6484_CR42","doi-asserted-by":"publisher","first-page":"e000630","DOI":"10.1136\/rmdopen-2017-000630","volume":"4","author":"AM Gulati","year":"2018","unstructured":"Gulati AM, Salvesen \u00d8, Thomsen RS, Kavanaugh A, Semb AG, Rollefstad S, Haugeberg G, Hoff M (2018) Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Tr\u00f8ndelag Health Study (HUNT). RMD Open 4:e000630. https:\/\/doi.org\/10.1136\/rmdopen-2017-000630","journal-title":"RMD Open"},{"key":"6484_CR43","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s10067-019-04528-y","volume":"38","author":"A Kibari","year":"2019","unstructured":"Kibari A, Cohen AD, Gazitt T, Bitterman H, Lavi I, Feldhamer I, Shalom G, Greenberg-Dotan S, Zisman D (2019) Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study. Clin Rheumatol 38:2069\u20132075. https:\/\/doi.org\/10.1007\/s10067-019-04528-y","journal-title":"Clin Rheumatol"},{"key":"6484_CR44","doi-asserted-by":"publisher","unstructured":"Kaine J, Song X, Kim G, Hur P, Palmer JB (2019) Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. administrative claims data. J Manag Care Spec Pharm 25:122\u2013132.https:\/\/doi.org\/10.18553\/jmcp.2018.17421","DOI":"10.18553\/jmcp.2018.17421"},{"key":"6484_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.semarthrit.2018.03.005","volume":"48","author":"R Cooksey","year":"2018","unstructured":"Cooksey R, Brophy S, Kennedy J, Gutierrez FF, Pickles T, Davies R, Piguet V, Choy E (2018) Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis. Semin Arthritis Rheum 48:367\u2013373. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.03.005","journal-title":"Semin Arthritis Rheum"},{"key":"6484_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00296-016-3614-0","volume":"37","author":"CB Nissen","year":"2017","unstructured":"Nissen CB, H\u00f8rslev-Petersen K, Primdahl J (2017) Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study. Rheumatol Int 37:113\u2013120. https:\/\/doi.org\/10.1007\/s00296-016-3614-0","journal-title":"Rheumatol Int"},{"key":"6484_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5152\/eurjrheum.2019.19029","volume":"6","author":"\u00d6 \u00d6zkul","year":"2019","unstructured":"\u00d6zkul \u00d6, Yaz\u0131c\u0131 A, Akt\u00fcrk AS, Karada\u011f DT, I\u015f\u0131k \u00d6O, Tekeo\u011flu S, Cefle A (2019) Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors? Eur J Rheumatol 6:174\u2013178. https:\/\/doi.org\/10.5152\/eurjrheum.2019.19029","journal-title":"Eur J Rheumatol"},{"key":"6484_CR48","doi-asserted-by":"publisher","first-page":"e16400","DOI":"10.1097\/md.0000000000016400","volume":"98","author":"R Queiro","year":"2019","unstructured":"Queiro R, Lorenzo A, Tej\u00f3n P, Coto P, Pardo E (2019) Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine (Baltimore) 98:e16400. https:\/\/doi.org\/10.1097\/md.0000000000016400","journal-title":"Medicine (Baltimore)"},{"key":"6484_CR49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/tcrm.s307102","volume":"17","author":"Q Wang","year":"2021","unstructured":"Wang Q, Luo Y, Chen M, Zheng X, Zhu W, Shen M, Kuang Y (2021) Comparison of behavioral risk factors and cardiometabolic comorbidities of psoriatic arthritis and psoriasis: a case-control study in chinese patients. Ther Clin Risk Manag 17:397\u2013404. https:\/\/doi.org\/10.2147\/tcrm.s307102","journal-title":"Ther Clin Risk Manag"},{"key":"6484_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41371-020-0348-y","volume":"35","author":"P Anyfanti","year":"2021","unstructured":"Anyfanti P, Gkaliagkousi E, Triantafyllou A, Koletsos N, Gavriilaki E, Galanopoulou V, Aslanidis S, Douma S (2021) Hypertension in rheumatic diseases: prevalence, awareness, treatment, and control rates according to current hypertension guidelines. J Hum Hypertens 35:419\u2013427. https:\/\/doi.org\/10.1038\/s41371-020-0348-y","journal-title":"J Hum Hypertens"},{"key":"6484_CR51","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10067-019-04519-z","volume":"38","author":"R Queiro","year":"2019","unstructured":"Queiro R, Lorenzo A, Tej\u00f3n P, Pardo E, Coto P (2019) Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease. Clin Rheumatol 38:2063\u20132068. https:\/\/doi.org\/10.1007\/s10067-019-04519-z","journal-title":"Clin Rheumatol"},{"key":"6484_CR52","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1093\/rheumatology\/keaa720","volume":"60","author":"E Toussirot","year":"2021","unstructured":"Toussirot E, Aubin F, Desmarets M, Wendling D, Aug\u00e9 B, Gillard J, Messica O, Guillot X, Laheurte C, Monnet E, Dumoulin G (2021) Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk. Rheumatology (Oxford) 60:2816\u20132825. https:\/\/doi.org\/10.1093\/rheumatology\/keaa720","journal-title":"Rheumatology (Oxford)"},{"key":"6484_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/03009742.2019.1672783","volume":"49","author":"AJ Landgren","year":"2020","unstructured":"Landgren AJ, Bilberg A, Eliasson B, Larsson I, Dehlin M, Jacobsson L, Klingberg E (2020) Cardiovascular risk factors are highly overrepresented in Swedish patients with psoriatic arthritis compared with the general population. Scand J Rheumatol 49:195\u2013199. https:\/\/doi.org\/10.1080\/03009742.2019.1672783","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"6484_CR54","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00296-022-05150-z","volume":"42","author":"D Erdem G\u00fcrsoy","year":"2022","unstructured":"Erdem G\u00fcrsoy D, Gezer HH, Acer Kasman S, Duru\u00f6z MT (2022) Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis. Rheumatol Int 42(11):2061\u20132067. https:\/\/doi.org\/10.1007\/s00296-022-05150-z","journal-title":"Rheumatol Int"},{"key":"6484_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","volume":"41","author":"S Gupta","year":"2021","unstructured":"Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41:275\u2013284. https:\/\/doi.org\/10.1007\/s00296-020-04775-2","journal-title":"Rheumatol Int"},{"key":"6484_CR56","doi-asserted-by":"publisher","first-page":"909760","DOI":"10.3389\/fimmu.2022.909760","volume":"13","author":"DM Schwartz","year":"2022","unstructured":"Schwartz DM, Parel P, Li H, Sorokin AV, Berg AR, Chen M, Dey A, Hong CG, Playford M, Sylvester M, Teague H, Siegel E, Mehta NN (2022) PET\/CT-based characterization of 18F-FDG uptake in various tissues reveals novel potential contributions to coronary artery disease in psoriatic arthritis. Front Immunol 13:909760. https:\/\/doi.org\/10.3389\/fimmu.2022.909760","journal-title":"Front Immunol"},{"key":"6484_CR57","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaad.2020.08.060","volume":"84","author":"W Xie","year":"2021","unstructured":"Xie W, Huang H, Deng X, Gao D, Zhang Z (2021) Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 84:701\u2013711. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.060","journal-title":"J Am Acad Dermatol"},{"key":"6484_CR58","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acr.23910","volume":"72","author":"C Fern\u00e1ndez-Carballido","year":"2020","unstructured":"Fern\u00e1ndez-Carballido C, Mart\u00edn-Mart\u00ednez MA, Garc\u00eda-G\u00f3mez C, Casta\u00f1eda S, Gonz\u00e1lez-Juanatey C, S\u00e1nchez-Alonso F, Garc\u00eda de Vicu\u00f1a R, Erausquin-Arruabarrena C, L\u00f3pez-Longo J, S\u00e1nchez MD, Corrales A, Quesada-Masachs E, Chamizo E, Barbadillo C, Bachiller-Corral J, Cobo-Iba\u00f1ez T, Turri\u00f3n A, Giner E, Llorca J, Gonz\u00e1lez-Gay MA (2020) Impact of comorbidity on physical function in patients with ankylosing spondylitis and psoriatic arthritis attending rheumatology clinics: results from a cross-sectional Study. Arthritis Care Res (Hoboken) 72:822\u2013828. https:\/\/doi.org\/10.1002\/acr.23910","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6484_CR59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00296-021-04971-8","volume":"42","author":"K Gok","year":"2022","unstructured":"Gok K, Nas K, Tekeoglu I, Sunar I, Keskin Y, Kilic E, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cuzdan N, Albayrak Gezer \u0130, Keskin D, Mulkoglu C, Resorlu H, Bal A, Duruoz MT, Kucukakkas O, Yurdakul OV, Alkan Melikoglu M, Aydin Y, Ayhan FF, Bodur H, Calis M, Capkin E, Devrimsel G, Ecesoy H, Hizmetli S, Kamanli A, Kutluk O, Sen N, Sendur OF, Tolu S, Toprak M, Tuncer T (2022) Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multicenter study. Rheumatol Int 42:659\u2013668. https:\/\/doi.org\/10.1007\/s00296-021-04971-8","journal-title":"Rheumatol Int"},{"key":"6484_CR60","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1093\/rheumatology\/keaa780","volume":"60","author":"C Ballegaard","year":"2021","unstructured":"Ballegaard C, Skougaard M, Guldberg-M\u00f8ller J, Nissen CV, Amris K, J\u00f8rgensen TS, Dreyer L, Kristensen LE (2021) Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study. Rheumatology (Oxford) 60:3289\u20133300. https:\/\/doi.org\/10.1093\/rheumatology\/keaa780","journal-title":"Rheumatology (Oxford)"},{"key":"6484_CR61","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13075-020-02350-5","volume":"22","author":"E Klingberg","year":"2020","unstructured":"Klingberg E, Bj\u00f6rkman S, Eliasson B, Larsson I, Bilberg A (2020) Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up. Arthritis Res Ther 22:254. https:\/\/doi.org\/10.1186\/s13075-020-02350-5","journal-title":"Arthritis Res Ther"},{"key":"6484_CR62","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Medina C, Molto A, Sieper J, Duru\u00f6z T, Kiltz U, Elzorkany B, Hajjaj-Hassouni N, Burgos-Vargas R, Maldonado-Cocco J, Ziade N, Gavali M, Navarro-Compan V, Luo SF, Monti S, Tae-Jong K, Kishimoto M, Pimentel-Santos FM, Gu J, Schiotis R, van Gaalen FA, Geher P, Magrey M, Ib\u00e1\u00f1ez Vodnizza SE, Bautista-Molano W, Maksymowych W, Machado PM, Landew\u00e9 R, van der Heijde D, Dougados M (2021) Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open 7(1):e001450. https:\/\/doi.org\/10.1136\/rmdopen-2020-001450","DOI":"10.1136\/rmdopen-2020-001450"},{"key":"6484_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00296-017-3895-y","volume":"38","author":"P Patel","year":"2018","unstructured":"Patel P, Rosen CF, Chandran V, Ye YJ, Gladman DD (2018) Addressing comorbidities in psoriatic disease. Rheumatol Int 38:219\u2013227. https:\/\/doi.org\/10.1007\/s00296-017-3895-y","journal-title":"Rheumatol Int"},{"key":"6484_CR64","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10067-018-4042-1","volume":"37","author":"R Queiro","year":"2018","unstructured":"Queiro R, Lorenzo A, Pardo E, Brandy A, Coto P, Ballina J (2018) Prevalence and type II diabetes-associated factors in psoriatic arthritis. Clin Rheumatol 37:1059\u20131064. https:\/\/doi.org\/10.1007\/s10067-018-4042-1","journal-title":"Clin Rheumatol"},{"key":"6484_CR65","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/1756-185x.14147","volume":"24","author":"A Loganathan","year":"2021","unstructured":"Loganathan A, Kamalaraj N, El-Haddad C, Pile K (2021) Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis 24:1112\u20131120. https:\/\/doi.org\/10.1111\/1756-185x.14147","journal-title":"Int J Rheum Dis"},{"key":"6484_CR66","first-page":"94","volume":"10","author":"G Rahmatpour Rokni","year":"2018","unstructured":"Rahmatpour Rokni G, Mobini M, Mohammadpour RA, Hoseinian Amiri A, Mohseni A, Bahar A (2018) The association between the components and features of metabolic syndrome in patients with psoriasis and psoriatic arthritis. Iran J Diabetes Obes 10:94\u2013101","journal-title":"Iran J Diabetes Obes"},{"key":"6484_CR67","doi-asserted-by":"publisher","unstructured":"Adeodato Ramos LM, Gomes KWP, de Saboia Mont'Alverne AR, Braga MV, Costa Vasconcelos AH, Rodrigues CEM (2021) High prevalence of metabolic syndrome in patients with psoriatic arthritis From northeastern Brazil: association with traditional cardiovascular risk factors and biologic disease-modifying antirheumatic drugs. JCR: J Clin Rheumatol 27(6S):S186-S192. https:\/\/doi.org\/10.1097\/rhu.0000000000001631","DOI":"10.1097\/rhu.0000000000001631"},{"key":"6484_CR68","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1093\/rheumatology\/keab365","volume":"60","author":"R Queiro","year":"2021","unstructured":"Queiro R, Fern\u00e1ndez S, Pardo E (2021) Hyperlipidaemia in psoriatic disease: higher prevalence in psoriatic arthritis and inverse association with systemic therapy. Rheumatology (Oxford) 60:3949\u20133951. https:\/\/doi.org\/10.1093\/rheumatology\/keab365","journal-title":"Rheumatology (Oxford)"},{"key":"6484_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41927-020-00123-w","volume":"4","author":"I Navarro-Mill\u00e1n","year":"2020","unstructured":"Navarro-Mill\u00e1n I, Young SR, Shurbaji S, McDavid C, Cornelius-Schecter A, Johnson B, Cherrington AL, Fraenkel L, Goodman SM, Curtis JR, Venkatachalam S, Safford MM (2020) Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis. BMC Rheumatol 4:26. https:\/\/doi.org\/10.1186\/s41927-020-00123-w","journal-title":"BMC Rheumatol"},{"key":"6484_CR70","doi-asserted-by":"publisher","unstructured":"Doca AM, Pomirleanu C, Ancuta C (2022) Where borders meet: psoriasic arthritis and the cardiovascular risk. Ro J Rheumatol 31(1). https:\/\/doi.org\/10.37897\/RJR.2022.1.7","DOI":"10.37897\/RJR.2022.1.7"},{"key":"6484_CR71","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/annrheumdis-2021-220782","volume":"80","author":"IJ Colunga-Pedraza","year":"2021","unstructured":"Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Rodriguez-Romero AB, Guajardo-Jauregui N, Cardenas-de la Garza JA, Lugo-Perez S, Meza-Garza A, Loya-Acosta J, Garza-Acosta AC (2021) Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque. Ann Rheum Dis 80:1629\u20131631. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220782","journal-title":"Ann Rheum Dis"},{"key":"6484_CR72","doi-asserted-by":"publisher","unstructured":"Bilim S, I\u00e7a\u011fasio\u011flu A, Akbal A, Kasapo\u011flu E, G\u00fcrsel S (2021) Assessment of subclinical atherosclerosis with ankle-brachial index in psoriatic arthritis: a case-control study. Arch Rheumatol 36:210\u2013218. https:\/\/doi.org\/10.46497\/archrheumatol.2021.8083","DOI":"10.46497\/archrheumatol.2021.8083"},{"key":"6484_CR73","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ijcard.2017.01.072","volume":"236","author":"A Dalbeni","year":"2017","unstructured":"Dalbeni A, Giollo A, Tagetti A, Atanasio S, Orsolini G, Cioffi G, Ognibeni F, Rossini M, Minuz P, Fava C, Viapiana O (2017) Traditional cardiovascular risk factors or inflammation: which factors accelerate atherosclerosis in arthritis patients? Int J Cardiol 236:488\u2013492. https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.072","journal-title":"Int J Cardiol"},{"key":"6484_CR74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00296-016-3617-x","volume":"37","author":"R Ib\u00e1\u00f1ez-Bosch","year":"2017","unstructured":"Ib\u00e1\u00f1ez-Bosch R, Restrepo-Velez J, Medina-Malone M, Garrido-Courel L, Paniagua-Zudaire I, Loza-Cortina E (2017) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound. Rheumatol Int 37:107\u2013112. https:\/\/doi.org\/10.1007\/s00296-016-3617-x","journal-title":"Rheumatol Int"},{"key":"6484_CR75","doi-asserted-by":"publisher","unstructured":"Luydmila Khimion AB (2019) Interconnection of traditional risk factors with the activity of the inflammatory process and atherosclerosis in patients with psoriatic arthritis. J Clin Med Kaz 1:32\u201336. https:\/\/doi.org\/10.23950\/1812-2892-JCMK-00663","DOI":"10.23950\/1812-2892-JCMK-00663"},{"key":"6484_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, S\u00f6dergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76:17\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"key":"6484_CR77","doi-asserted-by":"publisher","first-page":"7689208","DOI":"10.1155\/2019\/7689208","volume":"2019","author":"C Gonzalez-Martin","year":"2019","unstructured":"Gonzalez-Martin C, Grande Morais S, Pertega-Diaz S, Seoane-Pillado T, Balboa-Barreiro V, Veiga-Seijo R (2019) Concordance between the different cardiovascular risk scores in people with rheumatoid arthritis and psoriasis arthritis. Cardiol Res Pract 2019:7689208. https:\/\/doi.org\/10.1155\/2019\/7689208","journal-title":"Cardiol Res Pract"},{"key":"6484_CR78","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s10067-021-06002-0","volume":"41","author":"DA Galarza-Delgado","year":"2022","unstructured":"Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Guajardo-Jauregui N, Rodriguez-Romero AB, Lugo-Perez S, Cardenas-de la Garza JA, Arvizu-Rivera RI, Flores-Alvarado DE, Ilizaliturri-Guerra O, Garcia-Arellano G, Garza-Acosta AC (2022) Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients. Clin Rheumatol 41:1413\u20131420. https:\/\/doi.org\/10.1007\/s10067-021-06002-0","journal-title":"Clin Rheumatol"},{"key":"6484_CR79","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3899\/jrheum.181223","volume":"47","author":"MP Mart\u00ednez-Vidal","year":"2020","unstructured":"Mart\u00ednez-Vidal MP, Andr\u00e9s M, Jovan\u00ed V, Santos-Ram\u00edrez C, Romera C, Fern\u00e1ndez-Carballido C (2020) Role of carotid ultrasound and systematic coronary risk evaluation charts for the cardiovascular risk stratification of patients with psoriatic arthritis. J Rheumatol 47:682\u2013689. https:\/\/doi.org\/10.3899\/jrheum.181223","journal-title":"J Rheumatol"},{"key":"6484_CR80","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jbspin.2017.07.002","volume":"85","author":"MP Mart\u00ednez-Vidal","year":"2018","unstructured":"Mart\u00ednez-Vidal MP, Fern\u00e1ndez-Carballido C (2018) Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound. Joint Bone Spine 85:327\u2013332. https:\/\/doi.org\/10.1016\/j.jbspin.2017.07.002","journal-title":"Joint Bone Spine"},{"key":"6484_CR81","doi-asserted-by":"publisher","unstructured":"Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, Iliopoulos A, Chatzidionysiou K, Sfikakis PP, Tektonidou MG (2020) Higher depression rad diabetes mellitus. Ther Adv Musculoskelet Dis 12:1759720x20976975. https:\/\/doi.org\/10.1177\/1759720x20976975","DOI":"10.1177\/1759720x20976975"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06484-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06484-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06484-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:04:51Z","timestamp":1699884291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06484-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6484"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06484-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"No part of the present review, including text, graphics, and ideas, was published or copied from elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}